SINGAPORE, May 2, 2022 /PRNewswire/ — The aftermath of the COVID-19 pandemic is expected to have major impacts on the nature of cross border reproductive care where infertile couples and individuals in the past travelled extensively abroad to access medically assisted conception.
The 2022 Congress of the Asia Pacific Initiative on Reproduction (ASPIRE) heard that as the pandemic unfolded, access to fertility care in other countries was severely curtailed because of border closures, the adverse effects of COVID-19 during pregnancy, and vaccine hesitancy issues.
Australian fertility specialist, Dr Clare Boothroyd, said today restrictions on commercial surrogacy emerged as coronavirus and its variants spread throughout the world and there was a sudden shortage of donated sperm, eggs and embryos.
